Laboratorium Dna Genetyka Sądowasp. z o.o. + limited partnership
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2019-07-24
Limited partner contribution
37,000.00 PLN
Registered address
al. Zwycięstwa 96/98, 81-451 Gdynia, Poland
Electronic delivery address
AE:PL-10153-18839-IIGIW-22
Financials
Revenue history (in k)
From the notes
| Profit allocation | Dividend |
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 205 days for 2022).
- 202513/08/2026
- 202426/08/2025
- 202315/07/2024
- 202205/02/2024
- 202130/01/2023
- 202013/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 177.33kMedianUSD 55.66kAverageUSD 2.70m
Net profit
This companyUSD 99.29kMedianUSD -1.27kAverageUSD -92.16k
Operating costs
This companyUSD 67.86kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 133.19kMedianUSD 133.19kAverageUSD 3.03m
Industry
Partners
Manner of representation
The company is represented independently by the general partner in accordance with the established method of representation.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-11-01.
62 1050 1764 1000 0090 3200 6208
Debt
No entries in the National Debtors Register (KRZ).
Public aid
16 public aid cases recorded, with a total value of $99,018.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 1, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $25,814$25,814 | PREZYDENT MIASTA GDYNIA | |
| Apr 1, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $16,146$16,146 | PREZYDENT MIASTA GDYNIA | |
| Apr 1, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $12,908$12,908 | PREZYDENT MIASTA GDYNIA |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Phage Consultantssp. z o.o. | $193,130.82 | phageconsultants.com | ||
| Bactremsp. z o.o. | $181,958.36 | bactrem.pl | ||
| Pominnosp. z o.o. | $65,991.17 | pominno.pl | ||
| Receptonsp. z o.o. | $50,611.05 | receptonbiotech.com | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | ||
| ArthecS.A. | $10,911.16 | arthec.eu | ||
| MAP Your Dna Spólka z Ograniczoną Odpowiedzialnościąsp. z o.o. | $7,283.38 | mapyourdna.eu | ||
| Innervisionsp. z o.o. | $4.54 | innervision.pl | ||
| Astrofoodssp. z o.o. | – | astrofarms.space | ||
| UrtesteS.A. | – | urteste.com |
FAQ
The main business activity of Laboratorium Dna Genetyka Sądowa sp. z o.o. sp.k. focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on July 24, 2019.
The headquarters is located at: Al. Zwycięstwa 96/98, 81-451 Gdynia.
The share capital of the company is PLN 37,000 (approx. $9,995).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 177,326, representing a decrease of 0.5% compared to 2024.
Yes, the company recorded a net profit of USD 99,294 in 2025, meaning the company increased its profit by 23.1%.
The largest operating cost category falls under external services. This category amounted to USD 43,905 in 2025, representing 65% of all operating expenses.
Last updated: 2026-08-13